3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Dilafor AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix DF01, PL1 - Labor Onset and Length Abnormalities | Phase 2 | Completed | Dilafor AB | 365 | 2019-06-21 | 2025-05-06 |
| Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest DF 01, Oxytocin, Placebo - Labor, Obstetric | Phase 2 | Completed | Dilafor AB | 361 | 2016-12-01 | 2020-04-29 |
| Study to Assess Safety and Efficacy of DF01 in Reducing Prolonged Labor DF01, Placebo - Pregnancy, Labor | Phase 2 | Completed | Dilafor AB | 263 | 2007-04-01 | 2009-05-19 |
Oxytocin (1)
Sweden (3) · Finland (2) · Denmark (1)
Gunvor Ekman-Ordeberg, MD, PhD (2) · Gunvor Ekman-Ordeberg, MD, PhD, Study Chair, CMO (1) · Lena Granstrom, MD (1)
2019 (1)